Replies to post #669785 on NorthWest Biotherapeutics Inc (NWBO)

[User-840664]

Last Q was Nov 9th. Should be coming out soon.. This is a stock selling factory, and I have to assume the next Q will be much worse..

"Financing Activities

We received approximately $9.9 million of cash from issuance of 0.7 million shares of Series C convertible preferred stock during the nine months ended September 30, 2023. We received approximately $11.0 million cash from issuance of 0.7 million shares of Series C convertible preferred stock during the nine months ended September 30, 2022.

We received approximately $10.0 million and $5.0 million of cash from issuance the issuance of a loan to a commercial lender during the nine months ended September 30, 2023 and 2022, respectively. During the nine months ended September 30, 2022, we also received $0.6 million of cash from issuance of notes to multiple individual investors.

We received approximately $1.6 million and $10.0 million of cash from the exercise of warrants during the nine months ended September 30, 2023 and 2022, respectively.

We received approximately $9.5 million of cash from issuance of 13.1 million shares of common stock during the nine months ended September 30, 2022.

We received approximately $12.7 million of cash from issuance of convertible notes to individual lenders during the nine months ended September 30, 2023."